Vaccines for Lyme borreliosis: Facts and challenges

S Bodnárová, D Čížková, N Hudáková… - Folia Veterinaria, 2022 - sciendo.com
Lyme borreliosis (LB) is a multisystem infectious disease abundant in the northern countries
of the world and is caused by Borrelia species. Vaccination against LB is an effective way to …

Lyme borreliosis: reviewing potential vaccines, clinical aspects and health economics

R Šmit, MJ Postma - Expert review of vaccines, 2015 - Taylor & Francis
Lyme borreliosis (LB) is a multisystem infectious disease with a growing burden in many
parts of North America, Asia and Europe. Persistent infection of LB can usually be treated …

Novel targets and strategies to combat borreliosis

M Strnad, L Grubhoffer, ROM Rego - Applied microbiology and …, 2020 - Springer
Lyme borreliosis is a bacterial infection that can be spread to humans by infected ticks and
may severely affect many organs and tissues. Nearly four decades have elapsed since the …

A systematic review and meta-analysis for the adverse effects, immunogenicity and efficacy of Lyme disease vaccines: Guiding novel vaccine development

A Badawi, M Shering, S Rahman… - Canadian Journal of Public …, 2017 - Springer
BACKGROUND: Lyme borreliosis (LB) is the most prevalent arthropod-borne infectious
disease in North America. Currently, no vaccine is available to prevent LB in humans …

Human and veterinary vaccines for Lyme disease

NS O'Bier, AL Hatke, AC Camire… - Current issues in molecular …, 2021 - mdpi.com
Lyme disease (LD) is an emerging zoonotic infection that is increasing in incidence in North
America, Europe, and Asia. With the development of safe and efficacious vaccines, LD can …

Why is there still no human vaccine against Lyme borreliosis?

B Skotarczak - Folia Biologica (Kraków), 2015 - ingentaconnect.com
Lyme disease, transmitted by ticks, is a complex illness that can be difficult to diagnose but
easy to treat in most early cases, yet difficult in its latest stage. Every year, infections with …

Successful vaccination for Lyme disease: a novel mechanism?

M Exner - Expert Opinion on Biological Therapy, 2001 - Taylor & Francis
Borrelia burgdorferi sensu lato is the aetiologic agent of Lyme disease, which is a multi-
system disorder resulting from the transmission of organisms from an infected tick. According …

Lyme borreliosis vaccination: the facts, the challenge, the future

TJ Schuijt, JW Hovius, T van der Poll, AP van Dam… - Trends in …, 2011 - cell.com
Lyme disease, or Lyme borreliosis, the most prevalent arthropod-borne disease in the
Western world, is caused by spirochetes belonging to the Borrelia burgdorferi sensu lato …

Lyme disease vaccines face familiar challenges, both societal and scientific

L Shaffer - Proceedings of the National Academy of …, 2019 - National Acad Sciences
Just over 20 years ago, a Lyme disease vaccine called LYMErix was approved for sale in
the United States. Researchers designed the vaccine to prevent the transmission of the tick …

A Retrospective Study with a Commercial Vaccine against Lyme Borreliosis in Dogs Using Two Different Vaccination Schedules: Characterization of the Humoral …

CK Wilczek, J Wenderlein, S Hiereth, RK Straubinger - Vaccines, 2022 - mdpi.com
Lyme borreliosis, a multisystemic disease caused by spirochetes of the genus Borrelia, is
the most common tick-borne disease in the northern hemisphere. Differently from human …